EB
Eric Bjerkholt
DELAYED 1 MONTH
CHIEF FINANCIAL OFFICER; Director
CERUS CORP
Metagenomi Therapeutics, Inc.
Mirum Pharmaceuticals, Inc.
Surrozen, Inc./DE
Filings
6
Companies
4
Latest
Jun 9, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
Mirum Pharmaceuticals, Inc.
Eric Bjerkholt
CHIEF FINANCIAL OFFICER
Option Exercise
$63.4K
2,393 sh
Jun 10 1:21 AM
Jun 9, 2026
69
MIRMCLUSTER 3
Mirum Pharmaceuticals, Inc.
Eric Bjerkholt
CHIEF FINANCIAL OFFICER
Sale
$469.1K
5,000 sh
Jun 10 1:21 AM
Jun 8, 2026
73
MIRMCLUSTER 6
Mirum Pharmaceuticals, Inc.
Eric Bjerkholt
CHIEF FINANCIAL OFFICER
Sale
$670.2K
7,287 sh
Mar 17 11:30 PM
Mar 16, 2026
—
Mirum Pharmaceuticals, Inc.
Eric Bjerkholt
CHIEF FINANCIAL OFFICER
Option Exercise
—
13,334 sh
Mar 17 11:30 PM
Mar 15, 2026